Clinical Trials Directory

Trials / Completed

CompletedNCT04567927

Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19

Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With SARS-CoV-2 Infection

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Chiesa Alessandro Felice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess the frequency of the occurrence of a venous thrombosis in patients with the new Coronavirus disease, who are admitted to the Intensive Care Unit for impending respiratory failure requiring intubation and mechanical ventilation. Furthermore, the investigators aim at identifying potential risk factors for thrombosis and death.

Detailed description

Symptomatic infection with the severe acute respiratory syndrome coronavirus 2 ranges from mild to critical spectrum. About 80% of laboratory confirmed infections presented with mild symptoms, usually not requiring hospitalization. Critical disease requiring respiratory and/or circulatory support was reported in 5% of the subjects. Acute respiratory distress syndrome represents the most common complication in patients with severe disease. Several cases of venous thromboembolism in patients with laboratory confirmed infection have been reported, but it is unclear if this occurrence is higher in this specific patients' population. The purpose of the present study is to assess the prevalence of deep venous thrombosis in patients infected with SARS-CoV-2 admitted to the Intensive care Unit requiring invasive mechanical ventilation using vein ultrasonography.

Conditions

Interventions

TypeNameDescription
OTHERUltrasonographyVenous compression ultrasonography using real-time B-mode and colour doppler in transverse and longitudinal views

Timeline

Start date
2020-03-03
Primary completion
2020-05-28
Completion
2020-05-28
First posted
2020-09-29
Last updated
2020-09-29

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04567927. Inclusion in this directory is not an endorsement.